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Abstract
Background: The multidisciplinary perioperative and anaesthetic management of patients undergoing pelvic exenteration is
essential for good surgical outcomes. No clear guidelines have been established, and there is wide variation in clinical practice inter-
nationally. This consensus statement consolidates clinical experience and best practice collectively, and systematically addresses
key domains in the perioperative and anaesthetic management.
Methods: The modified Delphi methodology was used to achieve consensus from the PelvEx Collaborative. The process included
one round of online questionnaire involving controlled feedback and structured participant response, two rounds of editing, and
one round of web-based voting. It was held from December 2019 to February 2020. Consensus was defined as more than 80 per cent
agreement, whereas less than 80 per cent agreement indicated low consensus.
Results: The final consensus document contained 47 voted statements, across six key domains of perioperative and anaesthetic
management in pelvic exenteration, comprising preoperative assessment and preparation, anaesthetic considerations, perioperative
management, anticipating possible massive haemorrhage, stress response and postoperative critical care, and pain management.
Consensus recommendations were developed, based on consensus agreement achieved on 34 statements.
Conclusion: The perioperative and anaesthetic management of patients undergoing pelvic exenteration is best accomplished by
a dedicated multidisciplinary team with relevant domain expertise in the setting of a specialized tertiary unit. This consensus
statement has addressed key domains within the framework of current perioperative and anaesthetic management among patients
undergoing pelvic exenteration, with an international perspective, to guide clinical practice, and has outlined areas for future clinical
research.
Introduction
Perioperative and anaesthetic management undertaken for pelvic
exenteration requires close multidisciplinary and interprofes-
sional collaboration between the anaesthetic and surgical teams,
nursing staff and connected health members. These cases can be
complex and heterogeneous in terms of patient profile, tumour
characteristics and specific anatomical considerations, risk of
bleeding, anticipated operating time, and type of exenterative
and reconstructive procedure required. There have been no clear
guidelines established for the optimal perioperative and anaes-
thetic management of these patients, with wide variations across
different centres internationally.
Through this consensus statement, this international collabo-
rative group sought to consolidate clinical experience and best
practice collectively, based on current standards of care at this
point in time. The objective was to provide recommendations
and streamline perioperative strategies to improve surgical
outcomes among patients undergoing pelvic exenteration. The
PelvEx Collaborative has worldwide representation from spe-
cialist centres across five different continents, established
with the central aim of ascertaining factors and practices asso-
ciated with improved outcomes after pelvic exenterative sur-
gery. In addition, the purpose of the consensus was to support
and supplement perioperative clinical management by health-
care teams involved in treating patients undergoing pelvic exen-
terative.
The present consensus has been developed based on the
following six perioperative clinical domains: preoperative assess-
ment and preparation; anaesthetic considerations; perioperative
management; anticipating possible massive haemorrhage; stress
response and postoperative critical care; and pain management.
Although the consensus recommendations can guide surgical
and anaesthetic teams in their clinical practice, there is a need to
individualize the care of each patient undergoing pelvic exentera-
tion within the context of the prevailing clinical scenario. This
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consensus is not meant to supersede clinical judgment, but to
provide a framework to guide decision-making.
Methods
The modified Delphi methodology was used to achieve consensus
from the PelvEx Collaborative, an iterative process adopted to
gather consensus from specialist participants about issues within
a predetermined scope of clinical research, where expert opinion
is important in the absence of high-level definitive evidence1,2.
Held from December 2019 to February 2020, the significant
issues, challenges and considerations pertaining to perioperative
care and anaesthesia specific to patients undergoing pelvic exen-
teration were defined by the pelvic exenterative team at the
Royal Marsden Hospital. The Consensus Statement from the
PelvEx Collaborative, an international group comprising sur-
geons, anaesthetists, radiologists, specialist nurses, and physi-
cians including medical oncologists and radiation oncologists, is
representative of the multidisciplinary team (MDT) approach
necessary in the perioperative management of patients undergo-
ing pelvic exenteration.
The consensus process included one round of online question-
naire involving controlled feedback and structured participant re-
sponse, two rounds of editing, and one round of web-based voting.
The study was performed using the commercially available online
platform accessible through Typeform (Barcelona, Spain).
In round 1, there were 45 statements including three open-
ended questions; the feedback and issues raised formed the basis
of consensus statements for the subsequent round. In round 2,
28 key statements were fielded to the same group of participants.
For each statement, consensus was achieved with more than
80 per cent agreement; less than 80 per cent agreement indicated
low consensus. Owing to the conclusive responses obtained
after two questionnaire rounds, further rounds were deemed un-
necessary.
Each statement was graded by strength of recommendation
and level of evidence according to the following two predefined
scales, outlined in Tables 1 and 23. The medical evidence was criti-
cally evaluated for quality, including internal and external validity
for the patients undergoing pelvic exenteration. RCTs and meta-
analyses of RCTs were regarded as the highest level of evidence.
In the absence of high-quality evidence, consensus of expert opin-
ion was obtained on the relevant key aspects in the perioperative
management of patients undergoing pelvic exenteration.
Results
Section 1: Preoperative assessment and
preparation
For patients requiring pelvic exenteration, the aims of preopera-
tive assessment should be determining the level of surgical
fitness, ascertaining functional reserve and the ability to with-
stand periods of significant physiological stress, and the identifi-
cation of issues that can potentially result in adverse surgical
and anaesthetic outcomes. As patients undergoing pelvic exen-
teration comprise a heterogeneous group with diverse individual
patient profiles, medical co-morbidities and varying levels of per-
formance status, there has been no consensus on their optimal
risk stratification.
Given the inherent risk involved in this surgical procedure,
appropriate anaesthetist-led assessment and management of
various co-morbid conditions in the perioperative period can con-
siderably improve patient safety, especially among high-risk
patients4. Generally, these high-risk patients have medical condi-
tions that may include, but are not limited to, ischaemic heart
disease, heart failure, valvular heart disease, cardiac implantable
electronic device, pulmonary disease, and diabetes mellitus. The
increased risk of perioperative death is stratified based on the ag-
gregate of factors, including age, medical history, physiological
and nutritional parameters, and current performance status.
Although the ‘high-risk’ patient remains poorly defined, it has
been suggested that patients with a mortality risk greater than
5 per cent, and those undergoing a procedure carrying a mortality
risk of more than 5 per cent, be defined as high-risk surgical
patients5.
Over the years, the role of the anaesthetist has broadened, to
incorporate assessing the risk of anaesthesia, optimizing co-
morbid conditions if possible, selecting patients who may benefit
from additional regional anaesthetic modalities, and identifying
potential difficulties that may be encountered during the opera-
tion and subsequent postoperative course.
Cardiopulmonary exercise testing (CPET) provides an
integrated objective measure of aerobic fitness and functional
capacity, which in turn is a strong predictor of postoperative
morbidity and mortality6. It is also useful to detect unexpected
co-morbidity, thereby guiding further testing if necessary and
allowing possible optimization before surgery7. Ascertaining
functional capacity is a vital step in preoperative risk assessment
and is measured in metabolic equivalent of tasks (METs). While
1 MET represents basal metabolic rate, the inability to climb two
flights of stairs or run a short distance (4 or fewer METs) suggests
Table 1 Classes of recommendations
Class of recommendation Definition Suggested wording
I Evidence and/or general agreement that a given treatment or procedure is
beneficial, useful and effective
Is recommended/is indicated
II Conflicting evidence and/or a divergence of opinion about the usefulness/efficacy
of the given treatment or procedure
IIa Weight of evidence/opinion is in favour of usefulness/efficacy Should be considered
IIb Usefulness/efficacy is less well established by evidence/opinion May be considered
III Evidence/general agreement that the given treatment/procedure is not useful/
effective and may sometimes be harmful
Is not recommended




A Data derived from multiple RCTs or meta-analyses
B Data derived from a single RCT or large non-randomized
studies
C Consensus of expert opinion and/or small studies,
retrospective studies, registries
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poor functional capacity and is therefore associated with adverse
perioperative outcomes, particularly cardiac events8.
Cardiovascular complications are one of the leading causes of
postoperative morbidity and mortality9. The most validated risk-
scoring system, the Revised Cardiac Risk Index, which consists of
one procedural and five clinical risk factors10, has been shown
to have a linear relationship with the likelihood of perioperative
cardiac complications11. In a well and fit patient, routine cardio-
logical assessment is unnecessary on the premise of cost-
effective healthcare, due to the relatively low yield of additional
investigations that are therefore unlikely to alter clinical man-
agement. However, in the patient with more than two clinical
risk factors and poor functional capacity (4 or fewer METs), the
value of imaging stress-testing and myocardial perfusion imaging
before pelvic exenteration is well established8, as important prog-
nostic information can be derived based on the extent of ischae-
mic myocardium under stress.
With differing logistical considerations and arrangements in
the preoperative preparation across the numerous specialized
units worldwide, there was no consensus on whether patients
requiring pelvic exenteration should be admitted routinely the
night before surgery.
Consensus recommendations
1) If allocated time and resources, the anaesthetist undertaking the
case should personally preassess the high-risk patient requiring
pelvic exenteration, to help prepare for forthcoming surgery. Class
I/level C (84 per cent)
2) CPET, if available, is useful for assessing the patient’s functional
capacity before proceeding with pelvic exenteration. Class I/level
B (86 per cent)
3) At preassessment, if the patient has had a very good CPET result
and is deemed low risk for major perioperative morbidity, pelvic
exenteration can be undertaken. Class I/level B (100 per cent)
4) Patients with more than two clinical cardiac risk factors and
poor functional capacity (4 or fewer METs) should undergo
imaging stress-testing before pelvic exenteration. Class I/level C
(81 per cent)
5) Formal assessment by a cardiologist is not required routinely
for patients requiring pelvic exenteration. Class I/level C
(86 per cent)
Low consensus statement
1) Patients requiring pelvic exenteration do not need to be admitted
routinely the night before surgery, unless specifically indicated (for
example, for optimization). Class IIb/level C (60 per cent)
Section 2: Anaesthetic considerations
Pelvic exenteration is typically performed through an open
abdominal approach, although recent advancements in laparo-
scopic techniques and robotic surgery have enabled successful
minimally invasive pelvic exenterative procedures to be
performed. In view of the radical and complex nature of the
surgery and the expected extended duration required, general
anaesthesia is mandatory, whereas combined epidural and gen-
eral anaesthesia may be considered for additional postoperative
pain control12. Concomitant neuraxial blockade with epidural or
spinal anaesthesia further induces sympathetic blockade,
thereby attenuating the stress response associated with surgery.
There is evidence suggesting improved survival and a reduced in-
cidence of major cardiopulmonary and thromboembolic
Table 3 Summary of consensus statements
Section Recommendations
Preoperative assessment and preparation Anaesthetic preassessment of high-risk pelvic exenteration
Perform cardiopulmonary exercise testing
If more than two cardiac risk factors and four or fewer METs, perform imaging stress test-
ing before pelvic exenteration
Formal assessment by a cardiologist is not required routinely
Anaesthetic considerations Arterial line placement
Consider large-bore vascular catheter
Monitor arterial blood gases and haemoglobin regularly
Keep plasma lactate level below 1 mmol/l, or as low as possible
For high-risk pelvic exenteration procedures with expected duration longer than 12–18 h,
another anaesthetic colleague should assist
Dedicated anaesthesia team of nurses or operating department practitioners
Perioperative management Routine MDT briefing before induction of anaesthesia
Mechanical calf compression and TED stockings
Pressure-point protection padding
Careful leg positioning to avoid leg compartment syndrome; lower legs every 2–4 h
Prone position may be required for surgical access or myocutaneous flap reconstruction
Anticipating possible massive haemorrhage Cross-match at least 2 units of blood
Tranexamic acid if required
Consider thromboelastography in major haemorrhage
Blood products ready for immediate use if required
Stress response and postoperative critical care Noradrenaline as initial inotrope
Transfer to CCU for stabilization before extubation if patient develops major SIRS or
instability on inotropes
CCU admission for invasive monitoring and/or organ support
Goal-directed fluid therapy
Pain management Regional techniques (such as epidural) can reduce postoperative opioid use
Careful postoperative pain management protocol to maintain good regional anaesthesia
MET, metabolic equivalent of tasks; MDT, multidisciplinary team; TED, thromboembolic deterrent; CCU, critical care unit.The PelvEx Collaborative consensus
statement systematically addresses the perioperative and anaesthetic management of patients undergoing pelvic exenteration. Using the modified Delphi
methodology, recommendations across six key clinical domains were developed, comprising preoperative assessment and preparation, anaesthetic considerations,
perioperative management, anticipating possible massive haemorrhage, stress response and postoperative critical care, and pain management.
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problems, with more distinct benefits appreciated among
patients at high risk of developing complications13–17.
Although the administration of an inhaled volatile anaesthetic
is the commonest technique used for maintenance of anaesthe-
sia in the UK and Ireland18, there has been emerging evidence
indicating that volative anaesthetics are proinflammatory and
consequently affect immune processes including the immune
response to surgery, hence increasing the risk of postoperative
cancer recurrence and negatively impacting survival19–21. In total
intravenous anaesthesia (TIVA), the maintenance of general
anaesthesia is by intravenous infusion, with advantages such
as reduced risk of postoperative nausea, rapid recovery of
consciousness, and possibly superior oncological outcomes22–24.
Nevertheless, potential problems that may be encountered in
TIVA include failure in intended drug delivery, underdosing
resulting in accidental awareness, and overdosing. Furthermore,
inconsistent and inadequate training with this anaesthetic tech-
nique is an exacerbating factor, limiting its adoption among
anaesthetists18. Hence, there has been no consensus on the suit-
ability of TIVA in pelvic exenterative procedures, or on the intrao-
perative use of processed electroencephalographic monitoring to
prevent awareness and overdosing of anaesthetic drugs.
Selection of the most suitable haemodynamic and respiratory
intraoperative monitoring modalities, and appropriate integra-
tion of these various parameters can ensure a more comprehen-
sive understanding of the haemodynamic status of the patient.
This provides a broader clinical overview to facilitate intraopera-
tive decision-making, hence avoiding under- or over-
resuscitation, which are both detrimental25,26. In the context of
pelvic exenteration, it may not be possible to measure urine
output meaningfully in some patients where the bladder and/or
ureter(s) are resected. Therefore, besides continuous invasive BP
measurement, intra-arterial line placement allows for the analy-
sis of arterial blood gases and blood tests at regular time intervals
throughout the case. Where haemodynamic instability can be
expected, the use of vasopressors, inotropic agents, or large-
volume resuscitation with fluids and blood products mandates
the placement of a central venous line and/or large-bore vascular
catheter.
The need for a dedicated anaesthetic team for exenterative
procedures cannot be overemphasized, especially for high-risk
patients undergoing pelvic exenteration. It allows for centraliza-
tion of expertise and clinical experience, and ensures smooth
coordinated workflow, which is especially critical in resuscitative
scenarios. In anticipated high-risk exenterative cases with a sig-
nificant risk of clinical instability during the prolonged duration
of the procedure, further assistance from another anaesthetic
consultant or senior colleague should be considered.
Consensus recommendations
1) Arterial line placement for invasive monitoring during pelvic exen-
teration. Class I/level C (100 per cent)
2) Large-bore vascular catheter should be placed at the discretion of
the anaesthetist. Class I/level C (97 per cent)
3) Arterial blood gas and haemoglobin levels should be monitored
regularly during pelvic exenteration. Class I/level C (100 and
93 per cent respectively)
4) The plasma lactate level should be kept below 1 mmol/l or as low
as possible to ensure optimal perfusion and aerobic metabolism.
Class I/level C (80 per cent)
5) If the pelvic exenteration is anticipated to be high-risk and expected
duration is more than 12–18 h, another anaesthetic consultant or
colleague should be readily available to assist throughout the pro-
cedure. Class I/level C (89 per cent)
6) If possible, there should be a dedicated anaesthesia team of nurses
or operating department practitioners who have been specifically
trained to work with the anaesthetist during pelvic exenteration.
Class I/level C (86 per cent)
Low consensus statements
1) Central venous line placement is useful in most pelvic exenteration
procedures. Class IIa/level C (78 per cent)
2) TIVA is not suitable for pelvic exenteration. Class IIb/level C
(53 per cent)
3) Electroencephalographic/bispectral index monitoring is useful to
prevent awareness and overdosing of anaesthetic drugs during
pelvic exenteration. Class IIb/level C (46 per cent)
4) Non-invasive cardiac output (NICO) monitoring should be used
during pelvic exenteration to monitor preload and obtain optimal
cardiac output. Class IIb/level C (61 per cent)
Section 3: Perioperative management
The universal implementation of the WHO Surgical Checklist has
been shown that safety is beneficial for teamwork and communi-
cation in the operating theatre, thereby improving patient out-
comes27. Subsequently, the adoption of regular preoperative
team briefing demonstrated a significant decrease in work-flow
disruptions during surgery28. For more complex operations such
as pelvic exenteration, which require multidisciplinary and inter-
professional coordination of care over an extended duration of
surgery, a combined and structured team brief is essential. This
ensures a platform for open discussion of the case, facilitates col-
lective efforts to address anticipated issues, and allows ample
time for preparation or rectification if required.
Although it is widely accepted that patients undergoing major
abdominopelvic surgery are at increased risk of developing post-
operative venous thromboembolic (VTE) complications29,30, the
role of perioperative pharmacological thromboembolic prophy-
laxis remains debatable, especially among Asian surgical patients
who are known to have a significantly lower risk of developing
VTE complications31. No consensus was obtained regarding the
perioperative administration of low molecular weight heparin at
prophylactic dose within 24 h, whether before or after pelvic
exenterative surgery. Routine antibiotic prophylaxis should have
aerobic and anaerobic coverage, guided by the allergy status of
the patient.
There is substantial variation in the types of operating table
and mattress currently used by different centres worldwide. An
operating table suitably equipped with full mobility and flexibil-
ity, while retaining good stability, should be used. The table
should be able to cope with Lloyd-Davies, lithotomy, steep
Trendelenburg and supine positions, and allow for very low table
height should the need arise.
The operating table mattress may be used in conjunction with
a non-slip warming gel pad, combining their properties to achieve
the three aims of providing adequate support and comfort, help-
ing to maintain positional stability, and preserving normother-
mia for prolonged periods. Various warming systems are
available commercially to prevent inadvertent hypothermia dur-
ing the procedure, which can potentially contribute to coagulop-
athy, immune function suppression, cardiac and infective
complications. In contrast, should the core body temperature of
the patient be increased during surgery owing to an inflamma-
tory response from the extirpative phase of the surgery,
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consideration may be given for the warming adjuncts to be
stepped down or switched off.
Patient manoeuvring and extended duration in a fixed posi-
tion during surgery can potentially result in injuries sustained
while under anaesthesia. All patient positions can result in large
degrees of pressure concentrated disproportionately on small,
specific parts of the body surface, resulting in reduced perfusion
and tissue ischaemia, consequently leading to the development
of pressure injuries. The spectrum of severity can range from
erythema on intact skin or partial-thickness skin loss, to tissue
destruction involving subcutaneous fat, muscle and bone.
Cardiovascular disease, respiratory disease, diabetes mellitus,
anaemia and duration of surgery are significant perioperative
risk factors for the development of pressure injury as a result of
surgery under general anaesthesia32. Peripheral nerve injury can
occur where the nerve is subjected to stretch, compression, is-
chaemia, trauma, or a combination of these factors33, resulting
in pressure-related neuropathy, particularly among thin patients
who have undergone previous neoadjuvant chemoradiotherapy.
In the Lloyd-Davies and modified Lloyd-Davies positions, ele-
vation of the patient’s legs at a level above the heart causes a de-
crease in perfusion pressure, tissue ischaemia, and hypoxic
disruption of capillary endothelium, leading to interstitial oe-
dema and a rise in leg intracompartmental pressure34,35. This
can be further exacerbated by the Trendelenburg position for an
extended duration during surgery. Recent guidelines36 from a
multidisciplinary collaboration of colorectal, vascular and ortho-
paedic surgeons, acting on behalf of their specialty associations
in the UK and Ireland, have similarly recommended that the
patient’s legs should be kept at a level below the heart for the
maximum duration possible during pelvic surgery. When leg ele-
vation is required, the continuous duration of elevation should
be limited to 4 h36.
Special consideration should be given to the prone position,
which is frequently associated with cardiopulmonary issues.
Abdominal compression and increased intra-abdominal pressure
cause direct pressure on inferior vena cava, hence venous pool-
ing, decreased venous return and reduced cardiac output en-
sue37. Increased thoracic pressure and decreased respiratory
compliance in the prone position leads to an increase in peak air-
way pressure, thereby also decreasing venous return and cardiac
output38.
Besides physiological derangements, the prone position is
also frequently implicated with position-associated injuries.
Sufficient staffing and due care must be ensured during the
manoeuvring of the patient from supine to prone position.
Appropriate padding equipment is necessary to offset excessive
pressure from the face, particularly the nose and eyes.
Hyperflexion and hyperextension of the cervical spine should
be avoided. Careful positioning of the arms can help to prevent
brachial and/or ulnar neuropathy secondary to plexus and/nerve
impingement. Finally, the pressure points and skin must be
checked before proceeding with the next phase of the exentera-
tive surgery.
Consensus recommendations
1) For every patient requiring pelvic exenteration, the MDT briefing
should be held routinely before the induction of anaesthesia.
This ensures open communication and sharing of vital surgical,
anaesthetic, nursing and logistical concerns, thereby enabling coor-
dinated efforts to address any conflicting considerations, and
discussion of strategies to deal with possible difficulties. Class I/
level C (94 per cent)
2) Mechanical calf compression and thromboembolic deterrent
stockings should be used regularly during pelvic exenteration.
Class I/level C (86 per cent)
3) Careful pressure point protection padding, particularly at the
sacrum, should be used to prevent pressure ulcers. Class I/level C
(89 per cent)
4) To prevent leg compartment syndrome during pelvic exenteration,
careful vigilance on leg positioning is crucial. Class I/level C
(87 per cent)
5) Should leg elevation be required during a long pelvic exenterative
procedure, the legs should be brought down every 2–4 h, where
possible. Class I/level C (84 per cent)
6) Patients undergoing pelvic exenteration may need to be placed in
the prone position for surgical access or myocutaneous flap recon-
struction. Class I/level C (85 per cent)
7) Patients undergoing pelvic exenteration usually remain sufficiently
haemodynamically stable to prone, if required during the proce-
dure. I/C (92 per cent).
Low consensus statement
1) Low molecular weight heparin should be given routinely within
24 h of the perioperative period. Class IIa/level C (71 per cent)
Section 4: Anticipating possible massive
haemorrhage
Depending on the tumour location and structures involved by
tumour and/or fibrosis, an exenterative procedure may entail the
resection of pelvic organs, such as the bladder, prostate, seminal
vesicles, urethra, vagina and uterus, and/or part of the sacrum.
In addition, lateral pelvic side-wall and iliac vessel dissection
may be required39,40.
Although exenterative surgeons acknowledge that significant
bleeding can arise from the iliac vasculature and the sacral
venous plexus during pelvic exenteration, the risk of bleeding can
differ widely among patients. This is due largely to the heteroge-
neity existing in individual patient anatomy, type of exenterative
procedure required, and the presence of fibrosis and adhesions
from pelvic irradiation or previous surgery. The prospect of sud-
den massive haemorrhage during pelvic exenteration, where
rapid and aggressive resuscitation with intravenous fluids and
blood products is necessary to avoid haemodynamic instability
and the downstream cascade of complications, presents a major
challenge to the anaesthetist41.
Preoperative haemoglobin optimization is imperative;
however, owing to limited evidence regarding the ideal haemo-
globin level before surgery and lack of consensus on the most
efficacious strategy in treating varying degrees and different
causes of anaemia42, no standardized protocol has been imple-
mented widely among patients undergoing pelvic exenteration.
Intravenous iron infusion replenishes iron stores, allowing for a
rapid and more complete haematological response to mitigate
operative blood loss, reducing the risk of allogeneic blood trans-
fusion and perioperative morbidity, which can negatively impact
the oncological outcome.
The use of an antifibrinolytic agent such as tranexamic acid
(TXA) at the time of surgery may have a substantial impact in
mitigating the risk and severity of intraoperative bleeding43,44.
Dosing regimens vary among the various guidelines, but the ad-
ministration of 1 g TXA to all patients undergoing surgery where










egen user on 06 August 2021
significant blood loss is likely or possible can be considered, with
no evidence to support the use of high doses45–47.
Every institution should have a massive transfusion protocol
in place that is audited regularly to ensure logistical readiness
when needed. During active massive surgical haemorrhage,
transfusion should ideally be guided by the evolving clinical
circumstances and point-of-care testing of blood, such as throm-
boelastography (TEGVR : Haemonetics, Boston, MA, USA). With a
more rapid turnaround time, this provides a more accurate repre-
sentation of the dynamic coagulation profile, enabling targeted
blood component therapy and optimized component use.
Consensus recommendations
1) Patients undergoing pelvic exenteration may be transfused a vari-
able quantity of blood. Class I/level C (97 per cent)
2) There should be 2 units (or more) of blood cross-matched for each
patient. Class I/level C (84 per cent)
3) TXA can be given, if required, during surgery. Class I/level C
(81 per cent)
4) Patients undergoing pelvic exenteration may haemorrhage very
suddenly and quickly. Class I/level C (91 per cent)
5) There is a risk of major haemorrhage in exenterative procedures.
Class I/level C (97 per cent)
6) When exenterative procedures involve undergoing major haemor-
rhage, thromboelastography, if available, is useful to guide the ad-
ministration of clotting products. Class I/level C (84 per cent)
7) Blood products and reconstituted blood products should be freely
available for immediate use if demanded by the anaesthetist to
eradicate time delays. Class I/level C (85 per cent)
Low consensus statement
1) For exenterative procedures involving massive transfusion (accord-
ing to individual hospital protocol), haematologist guidance is often
not required. Class IIa/level C (76 per cent)
Section 5: Stress response and postoperative
critical care
The initial stress response to surgery is thought to be beneficial,
but the excessive and prolonged activation of the inflammatory
and immunological components of the response has been associ-
ated with adverse postoperative sequelae48,49. Despite the origi-
nal protective nature of the response, an overwhelming cytokine
storm, once elicited, can result in a massive inflammatory cas-
cade and the systemic inflammatory response syndrome (SIRS),
leading to secondary multiple organ dysfunction and death.
Although the precise risk of developing SIRS remains
unknown, patients undergoing pelvic exenteration invariably de-
velop a certain degree of inflammatory response, particularly as
extensive surgery in patients with cancer can cause the dysregu-
lated release of proinflammatory cytokines by activated leuco-
cytes, fibroblasts and endothelial cells. In patients undergoing
pelvic exenteration, SIRS may be exacerbated by other factors, in-
cluding coexisting infections and impaired nutritional status.
Furthermore, the greater likelihood of intraoperative blood trans-
fusion required in exenterative surgery may predispose the
patient to a more exaggerated immune response. This is evi-
denced by retrospective data indicating a significant association
between perioperative blood transfusion and the postoperative
systemic inflammatory response50,51.
The goals of perioperative anaesthetic management should
therefore include minimizing the stress response, through neu-
raxial blockade for example. In addition, early identification and
timely recognition of SIRS among patients undergoing pelvic ex-
enteration can allow appropriate supportive management to be
instituted to prevent further end-organ damage. This may consist
of the use of vasopressors and inotropic agents, mechanical ven-
tilatory support, and a period of treatment in the critical care
unit (CCU). Typically, CCU admission is necessary after exentera-
tive surgery52, facilitating continuous clinical monitoring, en-
hanced nursing care, and close critical care management in the
early postoperative phase.
Fluid management is an essential component of the postoper-
ative critical care of the patient undergoing pelvic exenteration.
The evidence comparing restrictive fluid strategy with goal-
directed fluid therapy (GDFT) in patients undergoing major non-
cardiac surgery remains inconclusive. In a recent systematic re-
view53, the data were derived from studies consisting of mainly
low-risk patients undergoing abdominal surgery. However, there
has been considerable evidence underlining the advantages of
GDFT in reducing morbidity and mortality in the high-risk surgi-
cal patient population54–56. GDFT aims to optimize the haemody-
namic status in order to achieve effective oxygen delivery to
tissues, through judicious fluid administration and inotrope use,
as guided by the monitoring of haemodynamic variables such as
cardiac output, cardiac index and stroke volume.
Cardiac output monitoring has traditionally been performed
with the pulmonary artery thermodilution technique using the
pulmonary artery catheter (PAC) and transpulmonary thermodi-
lution. With the emergence of less invasive and non-invasive
technologies for cardiac output monitoring, it has become used
less commonly in the setting of perioperative and intensive care.
Nevertheless, inconsistency and variability between the commer-
cially available NICO monitoring technologies57 have limited
their reliability and wider clinical applicability. Therefore, no con-
sensus was reached regarding the routine use of NICO monitor-
ing during surgery (Section 2) or for postoperative care following
pelvic exenterative procedures.
Consensus recommendations
1) Patients undergoing pelvic exenteration may develop a large sys-
temic inflammatory response (SIR), which may result in instability.
Class I/level C (95 per cent)
2) Should the patient develop SIRS, it is likely that they will require
inotropy. Class I/level C (89 per cent)
3) If clinically required, the recommended inotrope to use initially is
noradrenaline. Class I/level C (85 per cent)
4) Patients undergoing pelvic exenteration who develop major SIRS or
instability on inotropes should be transferred to the CCU for stabi-
lization before extubation. Class I/level C (94 per cent)
5) CCU admission is usually required in the perioperative period for
invasive monitoring and/or organ support in patients undergoing
pelvic exenteration. Class I/level C (81 per cent)
6) GDFT is the most appropriate fluid strategy after surgery. Class I/
level C (85 per cent)
Low consensus statements
1) The degree of SIR encountered is not predictable from the preopera-
tive assessment. Class IIb/level C (61 per cent)
2) In patients undergoing pelvic exenteration with SIRS, large vol-
umes of fluid can be given to maintain preload and adequate circu-
lation and metabolism, as measured by NICO and arterial blood
gases. Class IIb/level C (59 per cent)
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3) Patients undergoing pelvic exenteration should be adequately filled
after surgery to maintain optimal perfusion with lactate less than
1 mmol/l. Class IIb/level C (67 per cent)
4) Based on differences in individual patient profile and physiology,
and variability in the nature and extent of exenterative procedures,
it is not possible to have a standardized approach to fluid manage-
ment or inotropic support. Class IIa/level C (73 per cent)
Section 6: Pain management
Postoperative pain management should be a continuation of
intraoperative analgesia, utilizing a multimodal opioid-sparing
approach where possible. In the current era of enhanced recovery
after colorectal resection, minimization of systemic opioid use is
associated with earlier recovery of gastrointestinal function,
shorter duration of hospital stay, and fewer postoperative com-
plications58–60. Numerous adjunct local and regional analgesic
techniques, including epidural analgesia, spinal analgesia, intra-
venous lidocaine infusion, transversus abdominis plane block,
and continuous wound infusion of local anaesthetics via a cathe-
ter61, are effective postoperative pain control modalities, each
with their risks and benefits.
For instance, epidural analgesia is a consistently effective pain
control technique after major colorectal resection. It can help to
alleviate the sympathetic stress response through neuraxial
blockade. Additionally, when used in conjunction with a general
anaesthetic and maintained for at least 24 h after surgery, epidu-
ral analgesia decreases postoperative mortality, probably due to
concomitant reductions in major cardiopulmonary and gastroin-
testinal complications61,62. However, epidural analgesia can po-
tentially cause hypotension63, pruritus, incomplete block and,
rarely, severe neurological complications.
Satisfactory postoperative analgesia for the patient who has
undergone pelvic exenteration can be a multifaceted anaesthetic
challenge, regardless of the analgesic technique(s) chosen.
Although individual evaluation and comparative analyses of
these techniques are beyond the scope of this consensus state-
ment, there are limitations inherent to every technique due to
side-effects, variable pharmacokinetics and pharmacodynamics
of different drugs, and technical problems with drug administra-
tion. Moreover, apart from the interindividual differences in pain
threshold, the pain intensity is variable based on the different
surgical approaches, size of incision(s), and type of exenterative
and reconstructive procedures performed.
Similarly, the expected postoperative recovery milestones dif-
fer widely even among patients undergoing pelvic exenteration;
therefore, it may be necessary for the overall postoperative care
plan to be individualized according to the considerations and
issues unique to each patient. Furthermore, although it is unreal-
istic for entire enhanced recovery protocols following routine
colorectal resection to be applied to patients undergoing pelvic
exenteration, certain principles pertaining to medical and nutri-
tional optimization, pain control, mobilization, and exercise
interventions can be integrated into the recovery plan after exen-
terative procedures.
Consensus recommendations
1) Effective regional techniques (such as epidural, spinal anaesthesia,
regional blocks) or intravenous lidocaine are superior to intrave-
nous opiates. Class I/level A (84 per cent)
2) In reducing postoperative intravenous opioid use, epidural is useful
in pelvic exenterative procedures. Class I/level A (86 per cent)
3) Patients undergoing pelvic exenteration should have a careful post-
operative pain management protocol in place to ensure good re-
gional anaesthesia is maintained with practitioners who can
implement changes to epidural pain management. Class I/level C
(89 per cent)
Low consensus statements
1) Epidurals can have a positive effect on microcirculation and opti-
mal perfusion. Class IIb/level C (51 per cent)
2) The epidural catheter should be tunnelled so that it can potentially
last 10 days. Class IIb/level C (54 per cent)
Discussion
There is a need for further studies in various domains of the pre-
sent perioperative and anaesthetic management framework.
First, risk stratification of patients requiring pelvic exenteration
can help to define the high-risk population that may benefit from
more rigorous preoperative assessment and intensive periopera-
tive management such as invasive cardiac output monitoring
during and/or after the surgical procedure. Moreover, given the
diverse clinical practice and protocols among the exenterative
centres, this consensus can serve as a platform for more stream-
lined perioperative management and the development of coordi-
nated care pathways for patients undergoing pelvic exenteration.
Second, the evidence on the optimal fluid management strategy,
especially for high-risk patients undergoing major abdominal
surgery such as pelvic exenteration, is lacking at present.
Furthermore, there is considerable heterogeneity among different
patient profiles, as well as the different types of exenterative pro-
cedure performed with varying extents of blood loss. Lastly, with
the emerging adoption of enhanced recovery protocols world-
wide, future data and guidelines may better ascertain the appli-
cability of specific principles such as perioperative nutritional
optimization and exercise interventions, and evaluate the extent
of beneficial effect among patients requiring pelvic exenteration.
Although some tenets of enhanced recovery have been incorpo-
rated in the present consensus, such as thromboembolic prophy-
laxis, multimodal analgesia and avoidance of opiates, there are
other aspects for which consensus could not be achieved. For in-
stance, intraoperative anaesthetic protocols and fluid manage-
ment, and the use of minimally invasive surgical approaches64,
saw significant differences in practices across the various exen-
terative centres.
Table 3 provides a summary of consensus statements.
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